Articles dans des revues avec comité de lecture (100)
  1. 97. Devriendt, D., Yan, M., Kinnaert, E., Journé, F., Seo, H.-S., Van Houtte, P., & Leclercq, G. (2001). Effect of low dose irradiation on estrogen receptor level in MCF-7 breast cancer cells. International journal of cancer, 96(1), 32-40. doi:10.1002/1097-0215(20010220)96:1<32::AID-IJC4>3.0.CO;2-G
  2. 98. El Khissiin, A., Journé, F., Laïos, I., Seo, H.-S., & Leclercq, G. (2000). Evidence of an estrogen receptor form devoid of estrogen binding ability in MCF-7 cells. Steroids, 65(12), 903-913. doi:10.1016/S0039-128X(00)00206-3
  3. 99. Brohée, R., Nonclercq, D., Journé, F., Toubeau, G., Falmagne, P., Leclercq, G., Stiennon, J.-A., & Laurent, G. (2000). Demonstration of estrogen receptors and of estrogen responsiveness in the HKT-1097 cell line derived from diethylstilbestrol-induced kidney tumors. In vitro cellular & developmental biology. Animal, 36(10), 640-649. doi:10.1290/1071-2690(2000)036<0640:DOERAO>2.0.CO;2
  4. 100. Maaroufi, Y., Lacroix, M., Lespagnard, L., Journé, F., Larsimont, D., & Leclercq, G. (2000). Estrogen receptor of primary breast cancers: Evidence for intracellular proteolysis. Breast cancer research, 2(6), 444-454. doi:10.1186/bcr92
    5.   Rapports de recherche, comptes rendus, lettres à l'éditeur, working papers (1)
  5. 1. De Simone, P., Journé, F., Feron, P., Gelin, M., & Verzaro, R. (2004). Right colon perforation in a lung graft patient [12]. Transplantation, 77(12), 1919-1920. doi:10.1097/01.TP.0000129816.87919.A2
    6.   Participations à des congrès et colloques internationaux (4)
  6. 1. Place, F., Journé, F., Chaboteaux, C., Kheddoumi, N., Wattiez, R., & Body, J.-J. (2006). Proteomic profiling to search for new biomarkers of tumor-induced osteolysis. Paper session presented at Annual Meeting Belgian Association for Cancer Research (January 28th, 2006: Antwerp, Belgium).
  7. 2. Place, F., Journé, F., Kheddoumi, N., & Body, J.-J. (2005). Serum proteomics the use of albumin and globulin depletion improves the detection of new markers potentially related to breast cancer cell-induced osteolysis. Paper session presented at Annual Meeting Belgian Association for Cancer Research (January 22nd, 2005: Jette, Belgium).
  8. 3. Journé, F., Chaboteaux, C., Laurent, G., Place, F., Dumon, J.-C. P., & Body, J.-J. (2004). The Bisphosphonates clodronate and Ibandronates exert opposite effects on the growth of estrogen receptor-positive breast cancer cells cultured in steroid-free medium. Paper session presented at Annual meeting Belgian Association for Cancer Research (January 24th, 2004: Liège, Belgium).
  9. 4. Place, F., Journé, F., Mancini, I., Dumon, J.-C. P., & Body, J.-J. (2003). Standardization of two-dimensional electrophoresis of urine samples to search for new markers of tumor bone disease. Paper session presented at VIth International Conference on Cancer-Induced Bone Diseases (6: December 7-9, 2003: San Antonio, Texas, USA).
    10.   Thèses et mémoires (1)
  10. 1. Saloukas, K., Journé, F., & Kolivras, A. (2019). Étude de la valeur pronostique de la protéine p16 exprimée par le virus HPV dans les carcinomes épidermoïdes de la tête et du cou (Mémoire non-publié). Hôpital Erasme: ULB.
    11.   Direction de thèses (2)
  11. 1. El Hajj, P. (2015). New prognosis markers and new targets for therapy in high risk melanoma: evaluation of TYRP1 as a melanoma prognostic marker and its regulation by miRNA(s) (Thèse doctorale non-publiée). Université libre de Bruxelles, Faculté de Pharmacie, Bruxelles.
  12. 2. Krayem, M. (2015). MAPK pathway as a target for therapy in melanoma (Thèse doctorale non-publiée). Université libre de Bruxelles, Faculté de Pharmacie, Bruxelles.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 Suivant >>